Further, we subdivided the glioma samples according to IDH mutation status and 1p/19q deletion status and found higher GBE1 expression in IDH wild-type gliomas compared to IDH mutant ones (Figure 1E,H). This evidence concerns the gene GBE1 and central nervous system cancer.